Literature DB >> 21659553

T-cell depletion in GVHD: less is more?

Joseph H Antin1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21659553     DOI: 10.1182/blood-2011-04-348409

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia Activity.

Authors:  Shuting Zhao; Lingling Zhang; Jianfeng Han; Jianhong Chu; Hai Wang; Xilin Chen; Youwei Wang; Norm Tun; Lanchun Lu; Xue-Feng Bai; Martha Yearsley; Steven Devine; Xiaoming He; Jianhua Yu
Journal:  ACS Nano       Date:  2016-05-31       Impact factor: 15.881

Review 2.  Sequence analysis of T-cell repertoires in health and disease.

Authors:  Daniel J Woodsworth; Mauro Castellarin; Robert A Holt
Journal:  Genome Med       Date:  2013-10-30       Impact factor: 11.117

Review 3.  The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments.

Authors:  John P Veluchamy; Nina Kok; Hans J van der Vliet; Henk M W Verheul; Tanja D de Gruijl; Jan Spanholtz
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

4.  The immunogenic reaction and bone defect repair function of ε-poly-L-lysine (EPL)-coated nanoscale PCL/HA scaffold in rabbit calvarial bone defect.

Authors:  Bin Tian; Na Wang; Qingsong Jiang; Lijiao Tian; Lei Hu; Zhenting Zhang
Journal:  J Mater Sci Mater Med       Date:  2021-06-07       Impact factor: 3.896

5.  Expression of SOCS1 and SOCS3 genes in human graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Tae Hyang Lee; Ji Yoon Lee; Sohye Park; Seung Hwan Shin; Seung-Ah Yahng; Jae-Ho Yoon; Sung-Eun Lee; Byung-Sik Cho; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Chong-Won Park; Hee-Je Kim
Journal:  Blood Res       Date:  2013-03-25

Review 6.  Advance in Targeted Immunotherapy for Graft-Versus-Host Disease.

Authors:  Lingling Zhang; Jianhua Yu; Wei Wei
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.